220,657 results on '"Hepatocellular carcinoma"'
Search Results
2. ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma
3. Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies
4. THSWD upregulates the LTF/AMPK/mTOR/Becn1 axis and promotes lysosomal autophagy in hepatocellular carcinoma cells by regulating gut flora and metabolic reprogramming
5. Machine learning and multi-omics characterization of SLC2A1 as a prognostic factor in hepatocellular carcinoma: SLC2A1 is a prognostic factor in HCC
6. Precision oncology through next generation sequencing in hepatocellular carcinoma
7. Design, synthesis, and biological evaluation of Ponatinib-based N-Phenylpyrimidine-2-amine derivatives as novel fibroblast growth factor receptor 4 (FGFR4) selective inhibitors
8. Ultrasound nanobubble-based combinational strategies of loaded miR-107-3p and CD133 Ab for anti-PD-L1 and anti-hepatocellular cancer stem cells
9. Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma
10. Immunotherapy improved the efficacy of TACE or TACE plus MTTs in HCC patients: A meta-analysis
11. Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
12. Gold(I) complexes bearing EGFR-inhibiting ligands as anti-HCC agents through dual targeting of EGFR and TrxR
13. Exploring the phytochemical profile, antioxidant activity, and anticancer potential of Achillea millefolium extracts: In-vitro and in-silico investigation
14. The molecular receptor NKBB enhances the persistence and anti-hepatocellular carcinoma activity of GPC3 CAR-T cells
15. CT perfusion and MRI: A combined approach for hepatocellular carcinoma diagnosis and follow-up after locoregional treatment
16. Validation of proposed imaging criteria for estimating vessels encapsulating tumor clusters in hepatocellular carcinoma at CT and gadoxetic acid-enhanced MRI
17. AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane
18. Liver transplant for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease versus other etiologies: A meta-analysis
19. Current management of hepatobiliary malignancies between centers with or without a liver transplant program: A multi-society national survey
20. Toxin protein LukS-PV targeting complement receptor C5aR1 inhibits cell proliferation in hepatocellular carcinoma via the HDAC7–Wnt/β-catenin axis
21. Cancer-associated fibroblast-derived exosomes in cancer progression: A focus on hepatocellular carcinoma
22. Synthesis and biological evaluation of 4-((3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)quinoline derivatives as novel potential transforming growth factor-β type 1 receptor inhibitors for hepatocellular carcinoma
23. Spermidine synthase promotes liver cancer progression in a paracrine manner by altering the macrophage immunometabolic state
24. Worse clinical outcomes of TACE when liver function is decompensated in a cohort of patients with cirrhosis and HCC waiting for liver transplantation
25. Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma
26. Implications of surface architecture towards the development of a rapid and label-free Glypican-3 immunosensor
27. AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection
28. Immunotherapy in liver transplantation for hepatocellular carcinoma: A comprehensive review
29. Habitat radiomics based on CT images to predict survival and immune status in hepatocellular carcinoma, a multi-cohort validation study
30. Dual-drug loaded chondroitin sulfate embolization beads enhance TACE therapy for HCC by integrating embolization, chemotherapy, and anti-angiogenesis
31. Multi-omics analysis of transcriptome and proteome reveals that BAZ1A and BAZ2A have common and individual regulatory roles in hepatocellular carcinoma
32. High-throughput proteomics-guided biomarker discovery of hepatocellular carcinoma
33. Acetylation of E2F1 at K125 facilitates cell apoptosis under serum stress
34. Structure and expression of FAPP2 protein in hepatocellular carcinoma: Its effect and molecular mechanism on HepG2 and MHCC97H in clinical treatment
35. Explorations of novel MDR-related hub genes and the potential roles TRIM9 played in drug-resistant hepatocellular carcinoma
36. ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer
37. A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
38. Correlation of IL-10 and IL18 with the development of liver cirrhosis associated with hepatitis B virus infection: A systematic review
39. Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
40. Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: A comprehensive review
41. Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma
42. Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study
43. Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies
44. HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis
45. Current management and awareness of hepatitis coinfection in HIV care: A single-center retrospective study in Japan
46. Unlocking the potential of Traditional Chinese Medicine (TCM): Shipi Xiaoji formula (SPXJF) as a novel ferroptosis inducer in hepatocellular carcinoma
47. Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma
48. Identification and validation of an immune-related miRNA signature for predicting prognosis of hepatocellular carcinoma
49. A new platform of electrowetting-on-dielectric digital microfluidics for rapid detection of early-stage Hepatocellular Carcinoma(HCC) specific biomarker
50. Aggregation-induced magnetic coupling nanoassemblies that effectively switched from T2 to T1 contrast imaging for highly specific MRI detection of micron sized hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.